Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012307210> ?p ?o ?g. }
- W2012307210 endingPage "270" @default.
- W2012307210 startingPage "259" @default.
- W2012307210 abstract "The traditional method (TM), also known as the 3 + 3 up-and-down design, and the continual reassessment method (CRM) are commonly used in Phase I oncology trials to identify the maximum tolerated dose (MTD). The rolling-6 is a relative newcomer which was developed to shorten trial duration by minimizing the period of time during which the trial is closed to accrual for toxicity assessment. In this manuscript we have compared the performance of these three approaches via simulations not only with respect to the usual parameters such as overall toxicity, sample size and percentage of patients treated at doses above the MTD but also in terms of trial duration and the dose chosen as the MTD. Our results indicate that the toxicity rates are comparable across the three designs, but the TM and the rolling-6 tend to treat a higher percentage of patients at doses below the MTD. With respect to trial duration, rolling-6 leads to shorter trials compared to the TM but not compared to the CRM. Additionally, the doses identified as the MTD by the TM and the rolling-6 differ in a large percentage of trials. Our results also indicate that the body surface area-based dosing used in pediatric trials can make a difference in dose escalation/de-escalation patterns in the CRM compared to the cases where such variations are not taken into account in the calculations, even leading to different MTDs in some cases." @default.
- W2012307210 created "2016-06-24" @default.
- W2012307210 creator A5039391771 @default.
- W2012307210 creator A5065578155 @default.
- W2012307210 date "2010-05-01" @default.
- W2012307210 modified "2023-09-23" @default.
- W2012307210 title "A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials" @default.
- W2012307210 cites W1976397576 @default.
- W2012307210 cites W2002981832 @default.
- W2012307210 cites W2043446752 @default.
- W2012307210 cites W2069749929 @default.
- W2012307210 cites W2073567145 @default.
- W2012307210 cites W2073823496 @default.
- W2012307210 cites W2076108528 @default.
- W2012307210 cites W2078274740 @default.
- W2012307210 cites W2082007463 @default.
- W2012307210 cites W2098980231 @default.
- W2012307210 cites W2104438003 @default.
- W2012307210 cites W2106568960 @default.
- W2012307210 cites W2107733793 @default.
- W2012307210 cites W2118701470 @default.
- W2012307210 cites W2119602466 @default.
- W2012307210 cites W2125300671 @default.
- W2012307210 cites W2129050569 @default.
- W2012307210 cites W2147126709 @default.
- W2012307210 cites W2158740848 @default.
- W2012307210 doi "https://doi.org/10.1016/j.cct.2010.03.006" @default.
- W2012307210 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2863035" @default.
- W2012307210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20298812" @default.
- W2012307210 hasPublicationYear "2010" @default.
- W2012307210 type Work @default.
- W2012307210 sameAs 2012307210 @default.
- W2012307210 citedByCount "41" @default.
- W2012307210 countsByYear W20123072102012 @default.
- W2012307210 countsByYear W20123072102013 @default.
- W2012307210 countsByYear W20123072102014 @default.
- W2012307210 countsByYear W20123072102015 @default.
- W2012307210 countsByYear W20123072102016 @default.
- W2012307210 countsByYear W20123072102017 @default.
- W2012307210 countsByYear W20123072102019 @default.
- W2012307210 countsByYear W20123072102020 @default.
- W2012307210 countsByYear W20123072102021 @default.
- W2012307210 countsByYear W20123072102022 @default.
- W2012307210 countsByYear W20123072102023 @default.
- W2012307210 crossrefType "journal-article" @default.
- W2012307210 hasAuthorship W2012307210A5039391771 @default.
- W2012307210 hasAuthorship W2012307210A5065578155 @default.
- W2012307210 hasBestOaLocation W20123072102 @default.
- W2012307210 hasConcept C105795698 @default.
- W2012307210 hasConcept C107673813 @default.
- W2012307210 hasConcept C112758219 @default.
- W2012307210 hasConcept C121955636 @default.
- W2012307210 hasConcept C124952713 @default.
- W2012307210 hasConcept C126322002 @default.
- W2012307210 hasConcept C129848803 @default.
- W2012307210 hasConcept C142362112 @default.
- W2012307210 hasConcept C143998085 @default.
- W2012307210 hasConcept C144133560 @default.
- W2012307210 hasConcept C160234255 @default.
- W2012307210 hasConcept C162376815 @default.
- W2012307210 hasConcept C2777288759 @default.
- W2012307210 hasConcept C2777334693 @default.
- W2012307210 hasConcept C2777501473 @default.
- W2012307210 hasConcept C2781426361 @default.
- W2012307210 hasConcept C29730261 @default.
- W2012307210 hasConcept C33923547 @default.
- W2012307210 hasConcept C4577558 @default.
- W2012307210 hasConcept C535046627 @default.
- W2012307210 hasConcept C71924100 @default.
- W2012307210 hasConceptScore W2012307210C105795698 @default.
- W2012307210 hasConceptScore W2012307210C107673813 @default.
- W2012307210 hasConceptScore W2012307210C112758219 @default.
- W2012307210 hasConceptScore W2012307210C121955636 @default.
- W2012307210 hasConceptScore W2012307210C124952713 @default.
- W2012307210 hasConceptScore W2012307210C126322002 @default.
- W2012307210 hasConceptScore W2012307210C129848803 @default.
- W2012307210 hasConceptScore W2012307210C142362112 @default.
- W2012307210 hasConceptScore W2012307210C143998085 @default.
- W2012307210 hasConceptScore W2012307210C144133560 @default.
- W2012307210 hasConceptScore W2012307210C160234255 @default.
- W2012307210 hasConceptScore W2012307210C162376815 @default.
- W2012307210 hasConceptScore W2012307210C2777288759 @default.
- W2012307210 hasConceptScore W2012307210C2777334693 @default.
- W2012307210 hasConceptScore W2012307210C2777501473 @default.
- W2012307210 hasConceptScore W2012307210C2781426361 @default.
- W2012307210 hasConceptScore W2012307210C29730261 @default.
- W2012307210 hasConceptScore W2012307210C33923547 @default.
- W2012307210 hasConceptScore W2012307210C4577558 @default.
- W2012307210 hasConceptScore W2012307210C535046627 @default.
- W2012307210 hasConceptScore W2012307210C71924100 @default.
- W2012307210 hasIssue "3" @default.
- W2012307210 hasLocation W20123072101 @default.
- W2012307210 hasLocation W20123072102 @default.
- W2012307210 hasLocation W20123072103 @default.
- W2012307210 hasLocation W20123072104 @default.
- W2012307210 hasOpenAccess W2012307210 @default.
- W2012307210 hasPrimaryLocation W20123072101 @default.
- W2012307210 hasRelatedWork W2108776287 @default.